One indication that has been shown to have a strong correlation with OPN is metabolic-associated fatty liver disease (MAFLD) and the subsequent non-alcoholic steatohepatitis (NASH). Here, SPP1 is linked to metabolic dysfunction-associated steatohepatitis.